Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | POM121C | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
mRNA | PHF13 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
mRNA | AURKA | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-06 |
mRNA | WNK3 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
mRNA | RAVER2 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
mRNA | GAREM2 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
mRNA | RHOD | CTRPv2 | pan-cancer | AAC | -0.17 | 9e-06 |
mRNA | HECTD4 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
mRNA | KIF27 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-06 |
mRNA | ZNF423 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |